Response to a letter from J-P Chippaux and L Boyer entitled: "The 3+3 dose escalation design is not appropriate for antivenom dose finding." - Habib, A; Nasidi, A; Alder, N; Juszczak, E; David, R; Theakston, G; Warrell, D; Uk, E (TOXICON, 2010)